Mary Anne Heino

Mary Anne Heino serves as Chief Executive Officer and Executive Chairperson of Lantheus. Having previously served as the company’s Chief Executive Officer from August 2015 until March 2024, Ms. Heino brings nearly 20 years of executive level leadership and diverse pharmaceutical expertise in commercial strategy, operations management and business development. Prior to her appointment as CEO, Ms. Heino held executive leadership roles with increasing responsibility, joining the company in April 2013 as Chief Commercial Officer and being promoted to Chief Operating Officer in March 2015 where she oversaw commercial and technical operations. Before joining Lantheus, Ms. Heino held senior commercial and strategic leadership roles at Angelini Labopharm, Labopharm USA, and Centocor (a Johnson & Johnson company), following an early career in sales management at Janssen Pharmaceutica. She holds an MBA from NYU’s Stern School of Business, a BS in Nursing from the City University of New York, and a BS in Biology from SUNY Stony Brook.